Cannabis Growth Opportunity Corporation Provides Corporate Update

Published: February 6, 2020

Cannabis Growth Opportunity Corporation Provides Corporate Update

Cannabis Growth Opportunity Corporation, a cannabis focused investment corporation with both public and private cannabis holdings, announced that the Company’s board of directors has accepted the resignation of Brayden Sutton as a director of the Company, effective February 4, 2020. The Company extends its gratitude to Mr. Sutton for his contribution to the Company and wishes him the best in his future endeavours.

The Company also reports that its board of directors has accepted the resignation of Jamie Blundell as the Company’s President and Chief Operating Officer, effective February 4, 2020, who will be transitioning into an operating role within the industry over the coming weeks. Mr. Blundell will continue to serve the Company as a director.

Sean Conacher, Chief Executive Officer of CGOC, commented, “On behalf of the board, we wish to extend our gratitude to Mr. Blundell for his efforts since launching the Company’s IPO in 2018. We look forward to his ongoing support, as we enter the next phase of CGOC’s development, and collaborating with him at the board level.”

CGOC is an investment corporation that offers unique global exposure to the emerging global cannabis sector. CGOC’s main objective is to provide shareholders long-term total return through its actively managed portfolio of securities, both public and private, operating in, or that derive a portion of their revenue or earnings from products or services related to the cannabis industry.

Recent News

View All News Items

Latest Article

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).

 

Read Article